0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmacokinetic Testing Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-25O16731
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Pharmacokinetic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Pharmacokinetic Testing Market Research Report 2025

Code: QYRE-Auto-25O16731
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmacokinetic Testing Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmacokinetic Testing Market

Pharmacokinetic Testing Market

The global market for Pharmacokinetic Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacokinetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacokinetic Testing.
The Pharmacokinetic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmacokinetic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacokinetic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmacokinetic Testing Market Report

Report Metric Details
Report Name Pharmacokinetic Testing Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Research Institutions
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc., Creative Bioarray, Certara, L.P., Evotec AG, Pacific BioLabs, GVK Biosciences Private Limited, SGS SA, LGC Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmacokinetic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmacokinetic Testing Market report?

Ans: The main players in the Pharmacokinetic Testing Market are Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc., Creative Bioarray, Certara, L.P., Evotec AG, Pacific BioLabs, GVK Biosciences Private Limited, SGS SA, LGC Limited

What are the Application segmentation covered in the Pharmacokinetic Testing Market report?

Ans: The Applications covered in the Pharmacokinetic Testing Market report are Hospital, Clinic, Research Institutions

What are the Type segmentation covered in the Pharmacokinetic Testing Market report?

Ans: The Types covered in the Pharmacokinetic Testing Market report are Oral Dissolution Testing (FDC), Intravenous Titration Test (IVRT), Cell Line In-house Testing (ICR)

Recommended Reports

Pharma Diagnostics

Drug Testing & ADMET

Cancer & Disease Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral Dissolution Testing (FDC)
1.2.3 Intravenous Titration Test (IVRT)
1.2.4 Cell Line In-house Testing (ICR)
1.3 Market by Application
1.3.1 Global Pharmacokinetic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetic Testing Market Perspective (2020-2031)
2.2 Global Pharmacokinetic Testing Growth Trends by Region
2.2.1 Global Pharmacokinetic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmacokinetic Testing Historic Market Size by Region (2020-2025)
2.2.3 Pharmacokinetic Testing Forecasted Market Size by Region (2026-2031)
2.3 Pharmacokinetic Testing Market Dynamics
2.3.1 Pharmacokinetic Testing Industry Trends
2.3.2 Pharmacokinetic Testing Market Drivers
2.3.3 Pharmacokinetic Testing Market Challenges
2.3.4 Pharmacokinetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetic Testing Players by Revenue
3.1.1 Global Top Pharmacokinetic Testing Players by Revenue (2020-2025)
3.1.2 Global Pharmacokinetic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Pharmacokinetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmacokinetic Testing Revenue
3.4 Global Pharmacokinetic Testing Market Concentration Ratio
3.4.1 Global Pharmacokinetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetic Testing Revenue in 2024
3.5 Global Key Players of Pharmacokinetic Testing Head office and Area Served
3.6 Global Key Players of Pharmacokinetic Testing, Product and Application
3.7 Global Key Players of Pharmacokinetic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetic Testing Breakdown Data by Type
4.1 Global Pharmacokinetic Testing Historic Market Size by Type (2020-2025)
4.2 Global Pharmacokinetic Testing Forecasted Market Size by Type (2026-2031)
5 Pharmacokinetic Testing Breakdown Data by Application
5.1 Global Pharmacokinetic Testing Historic Market Size by Application (2020-2025)
5.2 Global Pharmacokinetic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmacokinetic Testing Market Size (2020-2031)
6.2 North America Pharmacokinetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmacokinetic Testing Market Size by Country (2020-2025)
6.4 North America Pharmacokinetic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetic Testing Market Size (2020-2031)
7.2 Europe Pharmacokinetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmacokinetic Testing Market Size by Country (2020-2025)
7.4 Europe Pharmacokinetic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetic Testing Market Size (2020-2031)
8.2 Asia-Pacific Pharmacokinetic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmacokinetic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmacokinetic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetic Testing Market Size (2020-2031)
9.2 Latin America Pharmacokinetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmacokinetic Testing Market Size by Country (2020-2025)
9.4 Latin America Pharmacokinetic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetic Testing Market Size (2020-2031)
10.2 Middle East & Africa Pharmacokinetic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmacokinetic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmacokinetic Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pharmaceutical Product Development, LLC
11.1.1 Pharmaceutical Product Development, LLC Company Details
11.1.2 Pharmaceutical Product Development, LLC Business Overview
11.1.3 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Introduction
11.1.4 Pharmaceutical Product Development, LLC Revenue in Pharmacokinetic Testing Business (2020-2025)
11.1.5 Pharmaceutical Product Development, LLC Recent Development
11.2 Charles River Laboratories International, Inc.
11.2.1 Charles River Laboratories International, Inc. Company Details
11.2.2 Charles River Laboratories International, Inc. Business Overview
11.2.3 Charles River Laboratories International, Inc. Pharmacokinetic Testing Introduction
11.2.4 Charles River Laboratories International, Inc. Revenue in Pharmacokinetic Testing Business (2020-2025)
11.2.5 Charles River Laboratories International, Inc. Recent Development
11.3 Creative Bioarray
11.3.1 Creative Bioarray Company Details
11.3.2 Creative Bioarray Business Overview
11.3.3 Creative Bioarray Pharmacokinetic Testing Introduction
11.3.4 Creative Bioarray Revenue in Pharmacokinetic Testing Business (2020-2025)
11.3.5 Creative Bioarray Recent Development
11.4 Certara, L.P.
11.4.1 Certara, L.P. Company Details
11.4.2 Certara, L.P. Business Overview
11.4.3 Certara, L.P. Pharmacokinetic Testing Introduction
11.4.4 Certara, L.P. Revenue in Pharmacokinetic Testing Business (2020-2025)
11.4.5 Certara, L.P. Recent Development
11.5 Evotec AG
11.5.1 Evotec AG Company Details
11.5.2 Evotec AG Business Overview
11.5.3 Evotec AG Pharmacokinetic Testing Introduction
11.5.4 Evotec AG Revenue in Pharmacokinetic Testing Business (2020-2025)
11.5.5 Evotec AG Recent Development
11.6 Pacific BioLabs
11.6.1 Pacific BioLabs Company Details
11.6.2 Pacific BioLabs Business Overview
11.6.3 Pacific BioLabs Pharmacokinetic Testing Introduction
11.6.4 Pacific BioLabs Revenue in Pharmacokinetic Testing Business (2020-2025)
11.6.5 Pacific BioLabs Recent Development
11.7 GVK Biosciences Private Limited
11.7.1 GVK Biosciences Private Limited Company Details
11.7.2 GVK Biosciences Private Limited Business Overview
11.7.3 GVK Biosciences Private Limited Pharmacokinetic Testing Introduction
11.7.4 GVK Biosciences Private Limited Revenue in Pharmacokinetic Testing Business (2020-2025)
11.7.5 GVK Biosciences Private Limited Recent Development
11.8 SGS SA
11.8.1 SGS SA Company Details
11.8.2 SGS SA Business Overview
11.8.3 SGS SA Pharmacokinetic Testing Introduction
11.8.4 SGS SA Revenue in Pharmacokinetic Testing Business (2020-2025)
11.8.5 SGS SA Recent Development
11.9 LGC Limited
11.9.1 LGC Limited Company Details
11.9.2 LGC Limited Business Overview
11.9.3 LGC Limited Pharmacokinetic Testing Introduction
11.9.4 LGC Limited Revenue in Pharmacokinetic Testing Business (2020-2025)
11.9.5 LGC Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmacokinetic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral Dissolution Testing (FDC)
 Table 3. Key Players of Intravenous Titration Test (IVRT)
 Table 4. Key Players of Cell Line In-house Testing (ICR)
 Table 5. Global Pharmacokinetic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmacokinetic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmacokinetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pharmacokinetic Testing Market Share by Region (2020-2025)
 Table 9. Global Pharmacokinetic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pharmacokinetic Testing Market Share by Region (2026-2031)
 Table 11. Pharmacokinetic Testing Market Trends
 Table 12. Pharmacokinetic Testing Market Drivers
 Table 13. Pharmacokinetic Testing Market Challenges
 Table 14. Pharmacokinetic Testing Market Restraints
 Table 15. Global Pharmacokinetic Testing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pharmacokinetic Testing Market Share by Players (2020-2025)
 Table 17. Global Top Pharmacokinetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Testing as of 2024)
 Table 18. Ranking of Global Top Pharmacokinetic Testing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pharmacokinetic Testing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pharmacokinetic Testing, Headquarters and Area Served
 Table 21. Global Key Players of Pharmacokinetic Testing, Product and Application
 Table 22. Global Key Players of Pharmacokinetic Testing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pharmacokinetic Testing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmacokinetic Testing Revenue Market Share by Type (2020-2025)
 Table 26. Global Pharmacokinetic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pharmacokinetic Testing Revenue Market Share by Type (2026-2031)
 Table 28. Global Pharmacokinetic Testing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pharmacokinetic Testing Revenue Market Share by Application (2020-2025)
 Table 30. Global Pharmacokinetic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pharmacokinetic Testing Revenue Market Share by Application (2026-2031)
 Table 32. North America Pharmacokinetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pharmacokinetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pharmacokinetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pharmacokinetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pharmacokinetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pharmacokinetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pharmacokinetic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pharmacokinetic Testing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pharmacokinetic Testing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pharmacokinetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pharmacokinetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pharmacokinetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pharmacokinetic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pharmacokinetic Testing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pharmacokinetic Testing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Pharmaceutical Product Development, LLC Company Details
 Table 48. Pharmaceutical Product Development, LLC Business Overview
 Table 49. Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product
 Table 50. Pharmaceutical Product Development, LLC Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 51. Pharmaceutical Product Development, LLC Recent Development
 Table 52. Charles River Laboratories International, Inc. Company Details
 Table 53. Charles River Laboratories International, Inc. Business Overview
 Table 54. Charles River Laboratories International, Inc. Pharmacokinetic Testing Product
 Table 55. Charles River Laboratories International, Inc. Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 56. Charles River Laboratories International, Inc. Recent Development
 Table 57. Creative Bioarray Company Details
 Table 58. Creative Bioarray Business Overview
 Table 59. Creative Bioarray Pharmacokinetic Testing Product
 Table 60. Creative Bioarray Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 61. Creative Bioarray Recent Development
 Table 62. Certara, L.P. Company Details
 Table 63. Certara, L.P. Business Overview
 Table 64. Certara, L.P. Pharmacokinetic Testing Product
 Table 65. Certara, L.P. Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 66. Certara, L.P. Recent Development
 Table 67. Evotec AG Company Details
 Table 68. Evotec AG Business Overview
 Table 69. Evotec AG Pharmacokinetic Testing Product
 Table 70. Evotec AG Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 71. Evotec AG Recent Development
 Table 72. Pacific BioLabs Company Details
 Table 73. Pacific BioLabs Business Overview
 Table 74. Pacific BioLabs Pharmacokinetic Testing Product
 Table 75. Pacific BioLabs Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 76. Pacific BioLabs Recent Development
 Table 77. GVK Biosciences Private Limited Company Details
 Table 78. GVK Biosciences Private Limited Business Overview
 Table 79. GVK Biosciences Private Limited Pharmacokinetic Testing Product
 Table 80. GVK Biosciences Private Limited Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 81. GVK Biosciences Private Limited Recent Development
 Table 82. SGS SA Company Details
 Table 83. SGS SA Business Overview
 Table 84. SGS SA Pharmacokinetic Testing Product
 Table 85. SGS SA Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 86. SGS SA Recent Development
 Table 87. LGC Limited Company Details
 Table 88. LGC Limited Business Overview
 Table 89. LGC Limited Pharmacokinetic Testing Product
 Table 90. LGC Limited Revenue in Pharmacokinetic Testing Business (2020-2025) & (US$ Million)
 Table 91. LGC Limited Recent Development
 Table 92. Research Programs/Design for This Report
 Table 93. Key Data Information from Secondary Sources
 Table 94. Key Data Information from Primary Sources
 Table 95. Authors List of This Report


List of Figures
 Figure 1. Pharmacokinetic Testing Picture
 Figure 2. Global Pharmacokinetic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmacokinetic Testing Market Share by Type: 2024 VS 2031
 Figure 4. Oral Dissolution Testing (FDC) Features
 Figure 5. Intravenous Titration Test (IVRT) Features
 Figure 6. Cell Line In-house Testing (ICR) Features
 Figure 7. Global Pharmacokinetic Testing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pharmacokinetic Testing Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinic Case Studies
 Figure 11. Research Institutions Case Studies
 Figure 12. Pharmacokinetic Testing Report Years Considered
 Figure 13. Global Pharmacokinetic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Pharmacokinetic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Pharmacokinetic Testing Market Share by Region: 2024 VS 2031
 Figure 16. Global Pharmacokinetic Testing Market Share by Players in 2024
 Figure 17. Global Top Pharmacokinetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Testing as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Pharmacokinetic Testing Revenue in 2024
 Figure 19. North America Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Pharmacokinetic Testing Market Share by Country (2020-2031)
 Figure 21. United States Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmacokinetic Testing Market Share by Country (2020-2031)
 Figure 25. Germany Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmacokinetic Testing Market Share by Region (2020-2031)
 Figure 33. China Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmacokinetic Testing Market Share by Country (2020-2031)
 Figure 41. Mexico Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmacokinetic Testing Market Share by Country (2020-2031)
 Figure 45. Turkey Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Pharmacokinetic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Pharmaceutical Product Development, LLC Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 49. Charles River Laboratories International, Inc. Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 50. Creative Bioarray Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 51. Certara, L.P. Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 52. Evotec AG Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 53. Pacific BioLabs Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 54. GVK Biosciences Private Limited Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 55. SGS SA Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 56. LGC Limited Revenue Growth Rate in Pharmacokinetic Testing Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart